KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Travere Therapeutics (TVTX) Non-Current Receivables (2016)

Historic Non-Current Receivables for Travere Therapeutics (TVTX) over the last 3 years, with Q2 2016 value amounting to $46.2 million.

  • Travere Therapeutics' Non-Current Receivables changed N/A to $46.2 million in Q2 2016 from the same period last year, while for Jun 2016 it was $46.2 million, marking a year-over-year change of. This contributed to the annual value of $45.6 million for FY2015, which is N/A changed from last year.
  • Travere Therapeutics' Non-Current Receivables amounted to $46.2 million in Q2 2016.
  • Over the past 5 years, Travere Therapeutics' Non-Current Receivables peaked at $46.2 million during Q2 2016, and registered a low of $137547.0 during Q1 2013.
  • For the 3-year period, Travere Therapeutics' Non-Current Receivables averaged around $36.6 million, with its median value being $45.6 million (2015).